Combination cancer immunotherapy and new immunomodulatory targets

KM Mahoney, PD Rennert, GJ Freeman - Nature reviews Drug …, 2015 - nature.com
Targeting immune checkpoints such as programmed cell death protein 1 (PD1),
programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has …

Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency …

NB Crux, S Elahi - Frontiers in immunology, 2017 - frontiersin.org
The genetic factors associated with susceptibility or resistance to viral infections are likely to
involve a sophisticated array of immune response. These genetic elements may modulate …

Exosomes in the diagnosis and treatment of renal cell cancer

S Boussios, P Devo, ICA Goodall, K Sirlantzis… - International journal of …, 2023 - mdpi.com
Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer originating from
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …

Heterogeneity of HLA-G expression in cancers: facing the challenges

A Lin, WH Yan - Frontiers in immunology, 2018 - frontiersin.org
Phenotypic heterogeneity has been observed in most malignancies, which represents a
considerable challenge for tumor therapy. In recent decades, the biological function and …

Natural killer cells unleashed: checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy

ZB Davis, DA Vallera, JS Miller, M Felices - Seminars in Immunology, 2017 - Elsevier
Natural killer (NK) cells have long been known to mediate anti-tumor responses without prior
sensitization or recognition of specific tumor antigens. However, the tumor microenvironment …

Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation

IG Motofei - Seminars in Cancer Biology, 2022 - Elsevier
Cancer research has been largely focused on the cellular and molecular levels of
investigation. Recent data show that not only the cell but also the extracellular matrix plays a …

Role of non-classical MHC class I molecules in cancer immunosuppression

G Kochan, D Escors, K Breckpot… - …, 2013 - Taylor & Francis
Growing neoplasms employ various mechanisms to evade immunosurveillance. The
expression of non-classical MHC class I molecules by both immune and malignant cells in …

Polymorphic Sites at the 3' Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population

G Martelli-Palomino, JA Pancotto, YC Muniz… - PloS one, 2013 - journals.plos.org
HLA-G molecule has well-recognized tolerogenic properties, and the encoding gene shows
lower frequency of polymorphism at the coding region but higher variability at regulatory …

Skin xenotransplantation: Historical review and clinical potential

T Yamamoto, H Iwase, TW King, H Hara, DKC Cooper - Burns, 2018 - Elsevier
Half a million patients in the USA alone require treatment for burns annually. Following an
extensive burn, it may not be possible to provide sufficient autografts in a single setting. Pig …

Human leukocyte antigen-G (HLA-G) expression in cancers: roles in immune evasion, metastasis and target for therapy

A Lin, WH Yan - Molecular Medicine, 2015 - Springer
Aberrant induction of human leukocyte antigen-G (HLA-G) expression has been observed in
various malignancies and is strongly associated with tumor immune escape, metastasis and …